-
Pharma to benefit from FDA digital health regulations
europeanpharmaceuticalreview
April 02, 2019
Companies that invest heavily now stand to steal a lasting lead over rivals that hesitate…
-
FDA Authorizes First Interoperable Insulin Pump
americanpharmaceuticalreview
February 18, 2019
The U.S. Food and Drug Administration (FDA) permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology (interoperable t:Slim X2) for delivering insulin under the skin for children and adults with diabetes....
-
WHO discusses digital health roadmap for Europe
pharmaphorum
February 15, 2019
The World Health Organisation has opened discussions into a roadmap for accelerating the digitisation of health systems in Europe.
-
Merck KGaA signs China digital health deal with Tencent
pharmaphorum
January 25, 2019
Germany’s Merck KGaA has signed a collaboration with Tencent to develop digital healthcare services in China.
-
Digital health innovators get boost in Yorkshire and Humber
pharmaphorum
January 16, 2019
A new NHS-backed scheme is to turbo-charge digital health innovation across England’s Yorkshire and Humber and region.
-
FDA announces further plans to hasten digital health R&D
pharmaphorum
January 10, 2019
The FDA has announced further details about its plans to hasten development of digital health products and tools.
-
FDA drafts pathway for digital health innovations
firstwordpharma
January 09, 2019
The FDA announced that it has drafted a regulatory framework to test new approaches for the review of digital health device applications. The framework is based on the Digital Health Precertification (Pre-Cert) programme that was piloted after the agency
-
2018 set benchmark for digital health investment – report
pharmaphorum
January 09, 2019
Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.
-
Merck shells out $2.4B for cutting-edge animal tech
fiercepharma
January 03, 2019
Bayer may be getting out of the animal health business, but Merck & Co. is plowing ahead—and in a new market to boot. The pharma giant is scooping up Antelliq, a company that specializes in digital ID and tracking
-
Digital therapeutics from apps to smart inhalers, brought to you by pharma
fiercepharma
December 25, 2018
While pharma-to-patient technologies have been around for several years, they’ve been largely experimental—and frankly, hit or miss.